These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 2182241

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
    Brochier ML, Quilliet L, Kulbertus H, Materne P, Letac B, Cribier A, Monassier JP, Sacrez A, Favier JP.
    Drugs; 1987; 33 Suppl 3():140-5. PubMed ID: 3315581
    [Abstract] [Full Text] [Related]

  • 5. Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Kasper W, Meinertz T, Wollschläger H, Bonzel T, Chen C, Hofmann T, Zeiher A, Drexler H, Just H.
    Drugs; 1987; 33 Suppl 3():112-6. PubMed ID: 3315575
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
    Seabra-Gomes R, Aniceto Silva J, Aleixo A, Real T, Freire I, Torres I, Freitas R, Crespo F.
    Drugs; 1987; 33 Suppl 3():169-74. PubMed ID: 3315586
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex.
    Kasper W, Meinertz T, Wollschläger H, Bonzel T, Wolff P, Drexler H, Hofmann T, Zeiher A, Just H.
    Am J Cardiol; 1986 Sep 01; 58(6):418-21. PubMed ID: 3529908
    [Abstract] [Full Text] [Related]

  • 15. Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction.
    Hogg KJ, Gemmill JD, Burns JM, Lifson WK, Rae AP, Dunn FG, Hillis WS.
    Lancet; 1990 Feb 03; 335(8684):254-8. PubMed ID: 1967720
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Hillis WS, Hornung RS, Hogg KJ, Hockings N, Burns JM, Dunn FG.
    Drugs; 1987 Feb 03; 33 Suppl 3():117-23. PubMed ID: 3315576
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.